Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care
Emeritus Professor of Internal Medicine - Hematology, Oncology and Blood and Marrow Transplantation

Contact Information


Primary Office
5992 John Pappajohn Pavilion (JPP)
Iowa City, IA 52242


MD, Medical, University of Leuven, Belgium
PhD, Medical, University of Leuven, Belgium
Resident, Catharina Hospital, Netherlands
Fellow, University of Leuven, Belgium
Fellow, Hematology(BMT), University of Leiden, Netherlands
Fellow, Hematology, University of Leiden, Netherlands

Center, Program and Institute Affiliations

Holden Comprehensive Cancer Center

Research Summary

Dr. Tricot's most recent clinical studies focus on not only attacking myeloma cells but also the microenvironment that supports the survival and growth of myeloma cells. His work aims at finding treatments that are non-cross-resistant with current chemotherapy and therefore can eradicate the drug-resistant myeloma cells. His work on detailed genetics of myeloma cells should allow individualized therapies to ensure the greatest efficacy, while minimizing toxicity. Over the last 15 years, the median survival for patients newly diagnosed with myeloma has, in large part due to this work, increased from 2.5 to more than 10 years. The complete remission rate has increased from 5% to 80% and one third of all patients are still in complete remission at 10 years.